Jobs rise 253000 in April signals resilient US labor market
April saw 253000 new jobs with unemployment at 3.4 percent, a 54-year low, while wages climbed 0.5 percent. The report downgrades February and March gains by 149000, splits labor participation, and spurs Fed debate on inflation and rate policy amid bank angst and stock swings.
MENTIONED IN THIS ARTICLE
Washington
America
Labor Department
Federal Reserve
Fed
Jerome Powell
New York
Apple
Wall Street
Treasury
U.S
Bill Northey
U.S. Bank Wealth Management
Bulls
The
Bears
First Republic Bank
Dow
Brian Coulton
Fitch Ratings
Institute For Supply Management
Tom Garretson
RBC Wealth Management
At&t Inc
AffirmHld
Newell Br
Alibaba
NiSource
Alphabt Cs
Nikola
Amazons Alphabt
As Vo
Northropg
NorwCruis
Amé Airlines
Apple Inc
Nvidia
Aptinyx H
EcoBrad
BkofAm
OwensCorn
Carnival
Carvana A
PacWsitBc
Palantir
Cedar F
Paramat
Cisco
CocaCola
Pelomintr
Coinbase
PepsiCo
Comcast
Petrobras
RiotBlok
FstHorizon
Schwab
FirstEngy
Shrwin
Fordm
Shopity S
Ubotv
Smucker
GenElec
SoFiTech
GenMotors
HomeDp
HuntBnesh
Deanom If A
Target mmunBio
Tauunh
US Banerp Keycorp
Vale SA
Kohls
VerizonCm
LincNat
WalMart
Wbrodisc As
Yit Inc
WeTrade
MarathDig
NYMX
CME
New York Mercantile Exchange
Chicago Board of Trade
Chicago Mercantile Exchange
ICE
Intercontinental Exchange
Mutua
AmrenBalAm
Invcamrca m
NwPrspctvAm
Wamtinvsam
Dodge & Cox Incl
Dodge & Cox IntiStkl
Dodge & Cox
Fidelity
Pimco Inciistl
Pimco TtlRetins
Schwab Sp500idx
Vanguard
Vanguard Diversay
Vanguard EqincAdmrl
Vanguard Hcadmrl
Vanguard Intrteadmrl
Vanguard InsidxIns
Vanguard InsidxInsPlus
Vanguard PrmCpAdmrl
Vanguard Stinvmgrdadmrl
Vanguard SmCpldxAdmrl
SEC
Associated Press
FDA to hold meeting on Opill OTC birth control pill
The FDA to review Perrigo's Opill application at a two day panel meeting in Washington to decide if a decades old progestin only pill can be sold without prescription. The vote will assess whether benefits outweigh risks and is not binding with a final decision expected summers.
MENTIONED IN THIS ARTICLE
Washington
Uss
Food and Drug Administration
Perrigo
FDA
U.S
Frederique Welgryn
Women’s Health
HRA Pharma
Pfizer
U.K
South America
Asia
Africa
Department of Health and Human Services
American Medical Association
Also Mentioned on This Page
Paul Wiseman
Perrigovia A
Opill
the Market IN Review
Dow Jones
Dow Industrials
Dow Transportation
Dow Utilities
NYSE
Nasdaq
S&p
Wilshire
Russell
Naspan
Lytt Inc
Wstnallib
DermTh
Carvanaa
ImmunBio
AirTrasp
AMD
AtlasLith
HallmkFn Rs
Nlight
GridDyn
Jubotv
OwensMin
Trapanian
Amazons
SmartLife
Syit Inc
Paramutb